Cloud-Based EHR Solutions - A Major Leap Into the Global Healthcare IT Industry

Primary Research:

The healthcare IT market comprises several stakeholders such as hospitals (small, mid-size, and large hospitals), ambulatory centers, diagnostic centers, TPAs, and stakeholders in corporate & government bodies. Primary sources from the supply side, including CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of healthcare IT developing companies, suppliers, and distributors, have been considered.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; trade directories; and databases such as D&B Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the healthcare IT market?

# What are the driving factors, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the healthcare IT market?

# What are the growth trends in the market at the segmental and overall market levels?

The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs. However, IT infrastructural constraints in developing countries are expected to restrain the growth of this market during the forecast period.

Although, the global healthcare IT market is largely fragmented in nature with presence of number of small and mid-sized vendors operating at local and regional levels, Cerner Corporation (US), Optum (US), Cognizant (US), Philips Healthcare (Netherlands) and Epic Systems (US) are some of the leaders in the healthcare IT solutions market.

Recent Developments in the Global Industry:

# In 2019, Philips launched Cares Aging & Caregiving service.

# In 2018, Change Healthcare launched Dx Gap Advisor

# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.

# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs.

# In 2018, Optum collaborated with Humana (US), MultiPlan (US) and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=252

“North America dominated the Healthcare IT market in 2018”

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Emerging Technologies & Major Leaders of the Global Neurovascular Devices Industry

The following are the major objectives of the study:

# To define, describe, and forecast the global neurovascular devices market on the basis of product, disease pathology, and region.

# To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, and opportunities)

# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

# To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players

# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

# To strategically profile the key market players and comprehensively analyze their market shares and core competencies

# To track and analyze competitive developments such as acquisitions, expansions, new product launches, agreements, and collaborations in the neurovascular devices/interventional neurology devices market

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847

The neurovascular devices market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Major factors driving the growth of this market include growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices.

Target Audience:

# Original Equipment Manufacturers (OEMs)

# Product Sales and Distribution Companies

# Healthcare Service Providers (Hospitals and Surgical Centers)

# Non-government Organizations

# Government Regulatory Authorities

# Research Laboratories and Academic Institutes

# Clinical Research Organizations (CROs)

# Research and Development Companies

# Market Research and Consulting Firms

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific is the fastest-growing geographic segment in the neurovascular devices/interventional neurology market. 

The large market growth of this geographic segment can be attributed to the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The key players in the neurovascular devices/interventional neurology market focused on various strategies such as product launches & enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase market shares in the global market. Product launches & enhancements were the key strategies adopted by major industry players to achieve the desired market growth during 2013-2016.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=847

This strategy was mainly adopted by Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China).

Apart from product launches & enhancements, many prominent players also adopted agreements & collaborations as the key growth strategy to strengthen market presence, enhance R&D capabilities, and to expand distribution networks to generate additional demand by sensitizing end users through an increase in availability of neurovascular products

Drug Discovery Services Industry - Expected Revenue Growth and Forthcoming Innovations

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain.

Recent Developments:

# In 2019, Charles River (US) and CHDI Foundation, Inc. (US), Extended collaboration on drug discovery and development for Huntington’s Disease by five years

# In 2019, Laboratory Corporation of America Holdings’s (US) opened the Covance Drug Development segment opened a new R&D Center in Shanghai, China—its largest facility in the Asia Pacific. This will help the company to grow its business in China and the APAC.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129

Report Objectives:

# To define, describe, and forecast the drug discovery services market based on process, type, drug type, therapeutic area, company type, and region

# To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and trends)

# To strategically analyze micro-markets for individual growth trends, prospects, and contributions to the overall market

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders operating in the market

# To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.

# To profile the key players and comprehensively analyze their services portfolios, market positions, and core competencies

# To track and analyze competitive developments such as service launches, partnerships, collaborations, agreements, expansions, and acquisitions in the market.

The global drug discovery services market size is projected to reach USD 19.1 billion by 2025 from USD 10.7 billion in 2020, at a CAGR of 12.1% from 2020 to 2025, the market will be driven by growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, thus necessitating increasing demand for outsourcing analytical testing and clinical trial services. 

Initiatives for research on rare diseases and orphan drugs, and focus on drug discovery are driving the growth of the global drug discovery services industry. Growth in biologics, patent expiries and emerging economies are expected to provide a wide range of growth opportunities for players in the market.

North America is expected to command the largest share of the drug discovery services market in 2020.

Based on the region, the global drug discovery services market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America is expected to command the largest share of the drug discovery services market. The large share of this market segment can be attributed majorly to the presence of well-established CROs, rising R&D expenditure by pharmaceutical & biopharmaceutical companies, and the availability of latest techniques, instruments, and facilities for drug discovery research.

Key Questions Addressed in the Report:

# What are the growth opportunities in the market across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of drug discovery services. Will this scenario continue during the next five years?

# What are the various drug discovery services and their respective market shares in the overall market?

# What are the new trends and advancements in the market?

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=138732129

The major players operating in this market Laboratory Corporation of America Holdings (US), Albany Molecular Research, Inc. (US), Charles River Laboratories International, Inc. (US), Evotec SE (Germany), Eurofins Scientific (Luxembourg), WuXi AppTec (China), GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Pharmaceutical Product Development, LLC (US), Syngene International Ltd. (India), and Selvita S.A. (Poland) among others.

Air Quality Monitoring System Market - Global Industry Forecasts to 2025

Primary Research:

The market comprises several stakeholders, such as demand-side (research laboratories, pharmaceutical & biotechnology companies, oil and gas companies, pharmaceutical companies, government organizations, and residential users) and the supply side (product manufacturers, contract manufacturers, and product distributors). Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to identify and collect information for this study.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183784537

The study involved four major activities in estimating the current market size for the air quality monitoring systems market. Exhaustive secondary research was done to collect information on the market and its different subsegments. 

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Recent Developments:

# In March 2019, Thermo Fisher Scientific (US) launched the TriPlus 500 Gas Chromatography Headspace Autosampler

# In February 2018, TSI (US) acquired 3M’s (US) Personal Safety Division, which includes offerings focused on noise, environmental, and heat stress monitoring. TSI also acquired 3M’s Oconomowoc, Wisconsin facility.

# In November 2017, Emerson (US) collaborated with Fluenta (Norway) to provide ultrasonic flare gas measurement solutions for the oil & gas and chemical industries. This collaboration was aimed at improving energy efficiency and compliance with regulations to monitor and report flare gas emissions across the globe

North America to dominate the AQMS market during the forecast period

Geographically, the AQMS market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest share of the market in 2019. Factors such as easy accessibility and fast adoption of advanced technologies among key stakeholders and the presence of stringent government regulations for effective pollution monitoring and control are contributing to the large share of the North American region.

The major players operating in the AQMS market include Thermo Fisher Scientific (US), Emerson Electric (US), General Electric (US), Siemens AG (Germany), Teledyne Technologies (US), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Spectris plc (UK), 3M Company (US), Honeywell International Inc (US), HORIBA, Ltd. (Japan), Merck KGaA (Germany), TSI Incorporated (US), Tisch Environmental (US), and Testo (Germany), among others.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=183784537

Key Questions Addressed by the Report:

# What are the growth opportunities related to the adoption of AQMS products across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of AQMS products. Will this scenario continue in the next five years?

# Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?

# What are the new trends and advancements in the market?

Advanced Apheresis Technologies - Major Leaders | Global Industry Dynamics

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Critical questions answered by this Study: 

# Where will these developments take the industry in the mid-to-long term?

# Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology?

# What are the recent trends in the apheresis market?

# What are the major market dynamics and their impact on overall market growth?

# What is the global scenario of the apheresis market?

The global apheresis market is expected to reach USD 2.7 billion by 2025 from an estimated value of USD 1.7 billion in 2019, growing at a CAGR of 8.1% during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Objectives of the Study:

# To define, describe, and forecast the global apheresis market by product, technology, application, procedure, end user, and region

# To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)

# To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the apheresis market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

# To profile key players in the apheresis market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as acquisitions; new product launches; collaborations, partnerships, and agreements; and R&D activities of the leading players in the global apheresis market

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Recent Developments:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.

# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.

# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Cell Isolation - Emerging Markets to Offer Major Growth Opportunities

Growth in the cell isolation market is mainly driven by the growing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine.

The study involved four major activities to estimate the current market size for the global cell isolation market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Biotechnology & biopharmaceutical companies to hold the largest share of the market during the forecast period.

Based on end users, the cell isolation market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest market share in 2018. The large share of this segment is attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology & biopharmaceutical companies and the increasing number of R&D facilities globally.

Recent Developments:

# In 2017, Beckman Coulter launched CytoFLEX Flow Cytometry.

# In 2017, Miltenyi Biotec launched MultiMACS X Device

# In 2017, MilliporeSigma entered into a partnership with Public Health England to distribute the European Bank of Induced Pluripotent Stem Cells (EBiSC)

# In 2016, Becton, Dickinson and Company (BD) launched BD FACSymphony

North America held the largest share of the market in 2018.

The cell isolation market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the cell isolation market, followed by Europe. The large share of the North American market is attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

The key strategies followed by most companies in the cell isolation market are product launches, expansions, agreements, and acquisitions to achieve growth in the cell isolation market. The product launches accounted for the largest share of the overall growth strategies adopted from 2015 to 2018.

Key questions addressed in the report:

# What are the growth opportunities offered by the cell isolation market across major regions in the next five years?

# Emerging countries have immense opportunities for growth in the cell isolation market. Will this scenario continue during the next five years?

# How will advancements in products offered by various companies affect the market scenario in the mid- to long-term?

# What are the new trends and advancements in the cell isolation market?

The major players in the cell isolation market are Beckman Coulter (US), Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

Stem Cell Banking Market - Emerging Industry Innovations & Future Forecasts

The global stem cell banking market is projected to reach USD 9,415.4 million by 2023 from USD 6,290.6 million in 2018, at a CAGR of 8.4% from 2018 to 2023.

Factors such as the growing awareness on the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing and storage; increase in hematopoietic stem cell transplantation (HSCT) procedures; and increasing investments in stem cell-based research are driving the growth of the stem cell banking market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220680183

Recent Developments:

# In 2017, Life Cell International (India), launched upgraded and enhanced its umbilical cord collection kit

# In 2017, Vita34 AG (Germany) acquired Seracell Pharma AG (Germany) to strengthen its position in the German stem cell banking market.

# In 2016, StemCyte India Therapeutics Pvt. Ltd. (India), a subsidiary of StemCyte (US) received accreditation from The Foundation for the Accreditation of Cellular Therapy (FACT) for both public and private stem cell banking services.

# In 2015, Cord Blood Registry (CBR) Systems (US) entered into a collaboration agreement with New York Stem Cell Foundation (US) to develop induced pluripotent stem cells from umbilical cords

Restraint: High operational costs of stem cell banking

Cell banks, tissue banks, and biobanks incur significant expenditure during the sample processing, quality testing, and sample preservation and storage processes. This does not include spending on the purchase and maintenance of premium-priced instruments, reagents, and consumables. This results in high operational costs for service providers. 

Moreover, increasingly stringent and mandatory regulatory requirements related to stem cell preservation and banking—as well as the costly licensing/approval process for the establishment of stem cell banks in developed nations—are expected to further contribute to the overall operational costs for stem cell banking service providers.

Key questions addressed in the report:

# What are the growth opportunities related to stem cell banking market across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of stem cell banking. Will this scenario continue in the next five years?

# What are the various types of stem cell banking services and their market share in the overall market?

# What are the new trends and advancements in the applications segment?

North America is expected to dominate the stem cell banking market in 2019

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share in 2019. The expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are driving the growth of the stem cell banking market in North America.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=220680183

The major players in the market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico); among others.